Perigon Wealth Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,295
Closed -$395K 1031
2024
Q2
$395K Sell
8,295
-291
-3% -$12.8K 0.01% 599
2024
Q1
$329K Buy
8,586
+1,298
+18% +$42.2K 0.01% 661
2023
Q4
$227K Buy
7,288
+703
+11% +$25.3K 0.01% 752
2023
Q3
$265K Buy
+6,585
New +$308K 0.01% 636
2023
Q2
Sell
-3,346
Closed -$214K 805
2023
Q1
$214K Buy
+3,346
New +$218K 0.01% 651
2022
Q4
Sell
-3,370
Closed -$238K 714
2022
Q3
$238K Buy
+3,370
New +$288K 0.02% 488
2021
Q1
Sell
-266
Closed -$21K 959
2020
Q4
$21K Buy
+266
New +$19.5K ﹤0.01% 1027

Other funds holding STAA

Perigon Wealth Management's STAA Position: Q3 2024 in Review

Perigon Wealth Management sold out of STAAR Surgical (STAA) in Q3 2024, closing a stake of 8,295 shares — an estimated $395K sold.

Perigon Wealth Management first reported a position in STAA in Q4 2020 and held it in 7 quarters. The position peaked at $395K in Q2 2024. 236 funds tracked by Wall St. Rank hold STAA as of Q3 2024.

  • Perigon Wealth Management reported no remaining STAAR Surgical position as of Q3 2024 after selling out during the quarter.
  • Perigon Wealth Management sold 8,295 STAAR Surgical shares in Q3 2024, an estimated $395K.
  • Perigon Wealth Management first reported a position in STAAR Surgical in Q4 2020 and held it in 7 quarters.
  • Perigon Wealth Management's STAAR Surgical position peaked at $395K in Q2 2024.
  • 236 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2024.

Based on Perigon Wealth Management's 13F filing for Q3 2024, filed 16 Oct 2024.